DataDerm注册表:绩效测量趋势的改善
研究分析了美国皮肤病学会DataDerm注册表中23项绩效测量指标的执行情况,发现各指标总体执行率为81.2%,且参与注册表并跟踪依从性可改善绩效指标依从性,从而提升医疗质量。
要点
- 23项绩效测量总体执行率为81.2%,提升潜力为18.8%。
- 各指标执行率从20.4%(AAD 1银屑病疾病活动评估)到99.9%(ACMS 1避免阿片类药物处方)不等。
- 参与多机构注册表并跟踪绩效可改善绩效依从性和医疗质量。
核心结论
- 参与多机构注册表并跟踪绩效测量依从性可改善绩效依从性,进而提升医疗质量。
研究设计与样本
- 基于美国皮肤病学会DataDerm注册表,分析23项绩效测量指标,每项指标至少有20名临床医生报告至少50名患者的数据。
主要发现
- 各绩效测量总体执行率范围为20.4%(AAD 1:银屑病疾病活动评估)至99.9%(ACMS 1:皮肤切除重建术后避免阿片类药物处方)。
- 23项测量中3项总体执行率超过95%。
- 所有23项测量的总体执行率为81.2%,表明总体提升潜力为18.8%。
- 在DataDerm参与的前五年中报告的9项绩效测量显示,在2016至2018年初期的参与年份中绩效持续改善,2019和2020年有一些波动。
关键数值与推荐
- 各绩效测量总体执行率范围为20.4%至99.9%。
- 23项测量中3项总体执行率超过95%。
- 所有23项测量的总体执行率为81.2%,总体提升潜力为18.8%。
临床怎么用
- 临床可通过参与多机构注册表并跟踪绩效测量依从性来改善绩效和医疗质量。
局限性
- 研究仅纳入至少20名临床医生报告且每名医生至少50名患者数据的绩效测量,可能影响代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Medicare's legacy quality reporting programs were consolidated into the Merit-Based Incentive Payment System (MIPS) in 2015. PURPOSE: The DataDerm registry of the American Academy of Dermatology was examined to understand the potential for and subsequent rate of improvement across 23 performance measures. METHODS: We examined the level of performance across 23 performance measures with at least 20 clinicians reporting on at least 50 patients' experience. We calculated the following values: the aggregate performance rate for each measure and the overall aggregate performance rate. RESULTS: The aggregate performance rate for each measure ranged from 20.4% for AAD 1 (Psoriasis: Assessment of Disease Activity), to 99.9% for measure ACMS 1 (Avoidance of Opioid Prescriptions for Reconstruction After Skin Resection). Three of 23 measures had an aggregate performance over 95%. The overall aggregate performance rate across all 23 measures was 81.2%, indicating an aggregate potential for improvement of 18.8% across the 23 measures. Nine performance measures reported across the first five years of DataDerm's existence were tracked through time to understand trends in performance through time. The performance across the nine performance measures meeting the inclusion criteria consistently improved in the initial years (2016 through 2018) of DataDerm participation and showed some variation in 2019 and 2020. CONCLUSIONS: These data provide evidence that the very act of participation in a multi-institutional registry and tracking compliance with performance measures can lead to improvements in compliance with the performance measures and therefore improvements in quality of care.
引用
- Fitzgerald ME, Van Beek MJ, Swerlick RA, et al. DataDerm: Improving trends in performance measurement. J Am Acad Dermatol. 2023. PMID: 38135157. doi:10.1016/j.jaad.2023.11.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。